There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

GLP-1 weight-loss drugs like Ozempic and Wegovy may help reduce alcohol cravings and heavy drinking, offering promising ...

According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...

A woman was left fighting for her life after using a so-called “weight loss jab” sourced from a salon with police making three arrests. The woman suffered internal injuries earlier after using an ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

If approved for the new indication, it could add a major new growth driver for semaglutide, which is already seeing sales rocket on the back of its use as Ozempic for diabetes, Wegovy for obesity ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).